CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
58 hedge funds and large institutions have $44.4M invested in CASI Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 15 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
30% less capital invested
Capital invested by funds: $63.2M → $44.4M (-$18.8M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
58
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.48M | |
| 2 | +$344K | |
| 3 | +$332K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$120K |
| 5 |
WSC
Wellington Shields & Co
New York
|
+$91.3K |
Top Sellers
| 1 | -$213K | |
| 2 | -$153K | |
| 3 | -$103K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$89.3K |
| 5 |
Barclays
London,
United Kingdom
|
-$80.6K |